Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer

被引：0
|
作者：
Macek, P.
Stricker, P.
Stevens, M.
Jagavkar, R.
Chalasani, V.
Haynes, A. M.
Matthews, J.
Brenner, P.
Golovsky, D.
Kooner, R.
O'Neill, G.
机构：
[1] Gen Univ Hosp, Prague, Czech Republic
[2] Garvan Inst Med Res, Sydney, NSW, Australia
来源：
BJU INTERNATIONAL | 2006年 / 97卷
关键词：
D O I：
10.1111/j.1464-410X.2006.06085_12.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] High dose rate (HDR) brachytherapy of localized prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 42 - 42
  • [32] HEAD TO HEAD COMPARISON OF CONDITIONAL ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER
    Bianchi, Marco
    Fossati, Nicola
    Gandaglia, Giorgio
    Matloob, Rayan
    Abdollah, Firas
    Capitanio, Umberto
    Deho, Federico
    Scattoni, Vincenzo
    Shariat, Shahrokh F.
    Karakiewicz, Pierre
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2015, 193 (04): : E681 - E681
  • [33] Comparisons of outcomes for patients with high-risk prostate cancer treated with brachytherapy, external beam radiation, or radical prostatectomy.
    Ciezki, Jay P.
    Singh, Harguneet
    Reddy, Chandana A.
    Campbell, Steven C.
    Ulchaker, James
    Angermeier, Kenneth
    Stephenson, Andrew J.
    Tendulkar, Rahul D.
    Stephans, Kevin L.
    Klein, Eric A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [34] Outcomes of High-Dose Rate Brachytherapy for Intermediate- to High-Risk Prostate Cancer at One Institution
    Lin, E. Y.
    Lee, A.
    Demanes, J.
    Kamrava, M.
    Venkat, P. S.
    Hagio, M. A.
    Zaide, L. B.
    Park, S. J.
    Zarate, C.
    Chang, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E927 - E927
  • [35] CLINICAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS AFFECTED BY LOCALIZED PROSTATE CANCER TREATED HDR BRACHYTHERAPY
    Soatti, Carlo Pietro
    Delishaj, Durim
    Frigerio, Cristina
    D'amico, Romerai
    Bonsignore, Francesco
    Fumagalli, Ilaria Costanza
    De Nobili, Giuseppe
    Cocchi, Alessandra
    Vola, Alessandra
    Sangalli, Giulia
    Declich, Fausto
    Colombo, Alessandro
    ANTICANCER RESEARCH, 2019, 39 (03) : 1618 - 1619
  • [36] RETROSPECTIVE ANALYSIS OF PATIENTS TREATED WITH HDR BRACHYTHERAPY FOR PROSTATE CANCER
    Yeung, Ka-Kit David
    Crook, Juanita
    Araujo, Cynthia
    Batchelar, Deidre
    Kim, David
    Petrik, David
    Rose, Tracey
    Bachand, Francois
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S33 - S34
  • [37] Prospective Evaluation of Stereotactic Radiotherapy for Low and Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dose Distribution
    Fuller, D. B.
    Mardirossian, G.
    Wong, D.
    McKellar, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S358 - S359
  • [38] Treatment of intermediate or high risk prostate cancer by dose escalation with HDR brachytherapy: Early toxicity and biochemical outcome of two treatment regimens
    Guix, B.
    Bratrina, J. M.
    Tello, J. I.
    Henriquez, I.
    Serrate, R.
    Vendrell, J. R.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S73 - S74
  • [39] External beam radiotherapy (EBRT) and high dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: Whole pelvis or prostate-only EBRT?
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Hoskin, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Pereira, R.
    More, E.
    Denley, H.
    Henry, A.
    Wylie, J.
    Hoskin, P.
    Bristow, R.
    Choudhury, A.
    West, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1086 - S1087
12345